Advertisement
Canada markets closed
  • S&P/TSX

    21,953.80
    +78.01 (+0.36%)
     
  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     
  • DOW

    39,331.85
    +162.33 (+0.41%)
     
  • CAD/USD

    0.7313
    +0.0030 (+0.41%)
     
  • CRUDE OIL

    83.17
    -0.21 (-0.25%)
     
  • Bitcoin CAD

    84,668.69
    -1,607.26 (-1.86%)
     
  • CMC Crypto 200

    1,332.23
    -12.28 (-0.91%)
     
  • GOLD FUTURES

    2,338.60
    -0.30 (-0.01%)
     
  • RUSSELL 2000

    2,033.87
    +3.81 (+0.19%)
     
  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    20,240.00
    +188.00 (+0.94%)
     
  • VOLATILITY

    12.03
    -0.19 (-1.55%)
     
  • FTSE

    8,121.20
    -45.56 (-0.56%)
     
  • NIKKEI 225

    40,074.69
    +443.63 (+1.12%)
     
  • CAD/EUR

    0.6801
    +0.0024 (+0.35%)
     

Can Canopy Growth Stock Finally Recover in 2024?

Worker tags plants at an industrial cannabis operation
Source: Getty Images

Written by Aditya Raghunath at The Motley Fool Canada

After touching all-time highs in October 2018, shares of Canopy Growth (TSX:WEED) currently trade 98.6% below record levels. Investor optimism was at its peak when Canada legalized marijuana for recreational use in October 2018. However, since then, the Canadian cannabis sector has been wrestling with industry-wide headwinds ranging from rising competition and oversupply of cannabis products to high inventory levels and negative profit margins.

In order to support their high cash-burn rates, several marijuana producers were forced to raise equity capital several times, diluting existing shareholder wealth significantly. Additionally, several established players, including Canopy Growth, acquired companies at a hefty premium to gain market share and expand their manufacturing capabilities. In the last few years, these overvalued acquisitions compelled cannabis producers to write down goodwill impairments that totalled billions of dollars.

ADVERTISEMENT

Valued at a market cap of $911 million, Canopy Growth stock has burnt massive investor wealth in recent years. Let’s see if the cannabis stock stages a recovery in 2024.

Canopy Growth continues to struggle

In fiscal 2024 (ended in March), Canopy Growth reported a net loss of $675.8 million, while its sales totalled $297.1 million. In fact, the company’s operating losses of $309.6 million were higher than its sales, which indicates it is nowhere close to profitability.

Now, investors generally invest in unprofitable companies as they hope steady top-line growth will improve economies of scale over time. However, in the fiscal fourth quarter (Q4) of 2024, Canopy Growth increased its sales by just 7% year over year to $72.8 million.

While Canopy has narrowed its losses, its cash outflow totalled $282 million in 2024, compared to an outflow of $557.5 million in 2023. With $206 million in balance sheet cash, Canopy Growth would have to raise equity capital within the next 12 months.

Will the U.S. offer a comeback opportunity?

Cannabis stocks, including Canopy Growth, have gained momentum in 2024 due to the prospect of marijuana legalization in the United States. Shares of Canopy Growth have risen by 40% year to date as the U.S. is all set to declassify marijuana as a Schedule I drug.

To gain a foothold in the world’s largest cannabis market, Canopy Growth created a special-purpose vehicle called Canopy USA. While the two entities are currently separate, they are likely to merge if and when the U.S. government legalizes pot at the federal level.

Canopy USA has already acquired companies such as Acreage Holdings, Jetty Extracts, and Wana Brands and is focused on consolidating these assets to benefit from cost synergies and operational efficiencies.

The prospect of legalization might seem compelling to investors. However, Canopy Growth will still need to compete with established multi-state operators such as Green Thumb and Cresco Labs, which have a sizeable presence in several regions. Moreover, Green Thumb reports a consistent profit and is free cash flow positive, making it a much better investment option right now.

What is the target price for WEED stock?

Canopy Growth is forecast to narrow its loss per share from $8.79 in fiscal 2024 to $1.71 per share in 2025 and $1.21 per share in 2026. While its losses are forecast to decline, it is still a few quarters away from profitability.

Analysts tracking WEED stock have a 12-month average target price of $9.13 for Canopy Growth, marginally higher than its current price of $8.90. The risk-reward profile for Canopy Growth is far from ideal, given you can invest in several other fundamentally strong stocks in 2024.

The post Can Canopy Growth Stock Finally Recover in 2024? appeared first on The Motley Fool Canada.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Canopy Growth wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $16,110.59!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the 10 stocks * Returns as of 6/20/24

More reading

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Cresco Labs and Green Thumb Industries. The Motley Fool has a disclosure policy.

2024